Okumura Corporation
Notice Regarding Recognition of Non-operating Expense (Foreign Exchange Forward Valuation Loss)
Disclosed recognition of a valuation loss on foreign exchange forwards in the interim financial results. The consolidated recognition of valuation gains/losses resulting from suspension of hedge accounting for Ishikari Bioenergy may have an impact, and note that this is not factored into the consolidated earnings forecast for the fiscal year ending March 2027.
Key Figures
- Valuation gains/losses on foreign exchange forwards: 941 million yen
- Fair value gains/losses (fiscal year-end): 6,918 million yen
- Timing of hedge accounting suspension: From Q2 of the fiscal year ending March 2025 onward
AI要約
Key Points
Following the suspension of hedge accounting for foreign exchange forwards of Ishikari Bioenergy LLC, the fair value gains/losses on unsettled foreign exchange forward positions at the fiscal year-end are being recognized in consolidated statements of profit or loss as non-operating expenses or non-operating income. While the consolidated earnings forecast was revised in the Q2 financial summary for the fiscal year ending March 2027, the impact of these gains/losses has not been incorporated into the company's net income for the current fiscal year.
Impact on Shareholder Returns and Outlook
Under the medium-term management plan's shareholder return policy, valuation gains/losses on foreign exchange forwards are excluded from payout ratio calculations. Future financial condition may be affected by currency movements, leaving uncertainty in earnings outlook.
Okumura Corporation
Company overview · Stock price · Financial data · All IR
